FlandersBio

FlandersBio, founded in 2004, is the networking organisation for the life sciences sector in Flanders and represents and supports close to 300 member companies. The key strategic objectives of FlandersBio are knowledge exchange and valorisation, human capital development, internationalization of the cluster activities and visibility, familiarization of the public with products derived from the sector and the further development of a supportive environment for the members of FlandersBio.

The FlandersBio network brings together companies with activities in the life sciences – companies that are for example developing biopharmaceuticals, medical technologies or agricultural or industrial biotech products. The network also welcomes research institutes, universities and providers of capital, services and technologies to the life sciences community.

Henk Joos is the Managing Director of FlandersBio.[1][2] He joined FlandersBio end of 2013 and was preceded by Ann De Beuckelaer, Ann Van Gysel and Els Vanheusden. Erwin Blomsma (General Manager, Aratana Therapeutics NV) is Chairman of the FlandersBio Board of Directors, and Dirk Reyn (Founder and CEO, Progress Pharma) Vice-Chairman.

See also

References
  1. "Henk Joos Appointed Managing Director of FlandersBio". Genomics Research from Technology Networks. Retrieved 2020-02-04.
  2. PharmaTimes (2014-01-14). "Henk Joos appointed Managing Director of FlandersBio". PharmaTimes. Retrieved 2020-02-04.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.